A Novel Non-Pharmacological Treatment of Diabetic Neuropathy

Status unconfirmed · Not applicable

Conditions studied: Diabetic Peripheral Neuropathy

In brief

The objective of the proposed work is to develop non-pharmacological interventions for diabetic peripheral neuropathy (DPN), to improve quality of life of individuals with diabetes, and reduce the prevalence of opiate prescription, sensation loss, falls, and deaths caused by DPN. To this end, the proposed study will investigate and determine the feasibility of the non-pharmacological intervention device. The feasibility study involves 16 participants, split evenly between pre-neuropathic diabetic and neuropathic diabetic participants. During the study, each group will receive the same 45-minute intervention on 10 days spread over no more than 14 days total. Feasibility will be determined by change in pain assessed before and after intervention.

Key facts

Study ID

NCT05414968

Run by

Auburn University

People needed

16

Starts

2023-03-22

Expected to finish

2025-06-01

Last updated by the study team

2023-08-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• diagnosis of type 2 diabetes for at least 5 years
• lab histories that verify participant's control or lack of blood sugars dating back for a period of 1-5 years

You may not qualify if…

• other diseases or impairments that could affect results (vascular disease verified from medical history
• ankle-brachial index (ABI) of 0.9 or less

Where it is running

• Auburn University — Auburn, Alabama, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.